Minocycline hydrochloride CAS: 13614-98-7
| Product Parameters | |
|---|---|
| Catalog No. | BK33AV |
| CAS.RN | 13614-98-7 |
| Molecular Formula | C23H28ClN3O7 |
| Molecular Weight | 493.94 g/mol |
| Purity | NLT 98% |
Product Overview
Minocycline hydrochloride is an important pharmaceutical intermediate widely used in the synthesis and preparation of antibiotics, exhibiting excellent biological activity and pharmacological properties. This product is suitable for compound screening, small-scale process validation, pilot-scale amplification, and commercial production during the R&D stage, serving as a crucial raw material for pharmaceutical companies in drug development and process optimization. With its stable chemical properties and reliable supply, minocycline hydrochloride can provide customers with high-quality, high-purity raw material support, helping them improve R&D efficiency and production quality.
Applications
- Antibiotic drug synthesis
- Customized production of pharmaceutical intermediates
- Drug process route development
- Pilot-scale and industrial production
- Drug impurity research and control
Quality & Supply Capability
English Name: Minocycline hydrochloride Properties: White to off-white crystalline powder, readily soluble in water, with strong basicity. Its structure contains aminocyclohexyl and dimethylamino groups, exhibiting good stability and suitability for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We can provide flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery time, and quality documentation. Furthermore, we have a professional technical team that can provide customers with full-process technical support from laboratory R&D to large-scale production, assisting customers in process development, route optimization, and project transformation, ensuring stable product quality, timely delivery, and compliant reliability.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive industry experience and professional qualifications. Full-scale supply capability, meeting diverse needs from laboratory to commercial production. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity standards, and packaging according to customer requirements. Provides supporting process optimization technology to help customers achieve efficient and stable process development and scale-up production.
Intermediates of Tigecycline
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA7C20 | Tigecycline API | 220620-09-7 |
| BK33AV | Minocycline hydrochloride | 13614-98-7 |
| BK8T12 | Chloroacetyl chloride | 79-04-9 |
| BK6K5E | (4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | 149934-17-8 |
| BK91JF | (4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide,sulfuric acid | 149934-20-3 |
| BK6B55 | (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-((tert-butylamino)acetamido)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | 156263-28-4 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 13614-98-7, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
